Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026

報告編號：2733788 ┊ 產業調研網 CIR.cn ┊ 推薦：

名　稱：Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026
編　號：2733788　
市場價：電子版21000元　　紙質+電子版22000元
優惠價：電子版19300元　　紙質+電子版19600元
電　話：400 612 8668、010-6618 1099、66182099、66183099
郵　箱：KF@Cir.cn　　《訂購協議》下載
提　示：如需中文、日文等其他語言版本，請與我們聯系。
網上訂購　　下載訂購協議　　 Pdf格式下載

Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026

字號：小中大報告內容：

1 mRNA Vaccine Market Overview

　1.1 Product Overview and Scope of mRNA Vaccine

　1.2 mRNA Vaccine Segment by Type

　　1.2.1 Global mRNA Vaccine Sales Growth Rate Comparison by Type (2021-2026)

　　1.2.2 Standardization Of Cancer Treatment mRNA Vaccine

　　1.2.3 Individualized Cancer Treatment mRNA Vaccine

　　1.2.4 Infectious Disease Treatment mRNA Vaccine

　　1.2.5 Infection Prevention mRNA Vaccine

　1.3 mRNA Vaccine Segment by Application

　　1.3.1 mRNA Vaccine Sales Comparison by Application: 2020 VS 2026

　　1.3.2 Infectious Disease

　　1.3.3 Cancer

　　1.3.4 Other

　1.4 Global mRNA Vaccine Market Size Estimates and Forecasts

　　1.4.1 Global mRNA Vaccine Revenue 2015-2026

　　1.4.2 Global mRNA Vaccine Sales 2015-2026

　　1.4.3 mRNA Vaccine Market Size by Region: 2020 Versus 2026

2 Global mRNA Vaccine Market Competition by Manufacturers

　2.1 Global mRNA Vaccine Sales Market Share by Manufacturers (2015-2020)

　2.2 Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020)

　2.3 Global mRNA Vaccine Average Price by Manufacturers (2015-2020)

　2.4 Manufacturers mRNA Vaccine Manufacturing Sites, Area Served, Product Type

　2.5 mRNA Vaccine Market Competitive Situation and Trends

　　2.5.1 mRNA Vaccine Market Concentration Rate

　　2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

　　2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

　2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

　2.7 Primary Interviews with Key mRNA Vaccine Players (Opinion Leaders)

3 mRNA Vaccine Retrospective Market Scenario by Region

　3.1 Global mRNA Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020

　3.2 Global mRNA Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

　3.3 North America mRNA Vaccine Market Facts & Figures by Country

　　3.3.1 North America mRNA Vaccine Sales by Country

　　3.3.2 North America mRNA Vaccine Sales by Country

　　3.3.3 U.S.

　　3.3.4 Canada

　3.4 Europe mRNA Vaccine Market Facts & Figures by Country

　　3.4.1 Europe mRNA Vaccine Sales by Country

　　3.4.2 Europe mRNA Vaccine Sales by Country

　　3.4.3 Germany

　　3.4.4 France

　　3.4.5 U.K.

全:文：http://www.5269660.cn/8/78/Global-mRNA-Vaccine-Industry-Analysis-and-Trends-Analysis-Report-2020-2026.html

　　3.4.6 Italy

　　3.4.7 Russia

　3.5 Asia PacifiA Vaccine Market Facts & Figures by Region

　　3.5.1 Asia PacifiA Vaccine Sales by Region

　　3.5.2 Asia PacifiA Vaccine Sales by Region

　　3.5.3 China

　　3.5.4 Japan

　　3.5.5 South Korea

　　3.5.6 India

　　3.5.7 Australia

　　3.5.8 Taiwan, China

　　3.5.9 Indonesia

　　3.5.10 Thailand

　　3.5.11 Malaysia

　　3.5.12 Philippines

　　3.5.13 Vietnam

　3.6 Latin America mRNA Vaccine Market Facts & Figures by Country

　　3.6.1 Latin America mRNA Vaccine Sales by Country

　　3.6.2 Latin America mRNA Vaccine Sales by Country

　　3.6.3 Mexico

　　3.6.3 Brazil

　　3.6.3 Argentina

　3.7 Middle East and Africa mRNA Vaccine Market Facts & Figures by Country

　　3.7.1 Middle East and Africa mRNA Vaccine Sales by Country

　　3.7.2 Middle East and Africa mRNA Vaccine Sales by Country

　　3.7.3 Turkey

　　3.7.4 Saudi Arabia

　　3.7.5 U.A.E

4 Global mRNA Vaccine Historic Market Analysis by Type

　4.1 Global mRNA Vaccine Sales Market Share by Type (2015-2020)

　4.2 Global mRNA Vaccine Revenue Market Share by Type (2015-2020)

　4.3 Global mRNA Vaccine Price Market Share by Type (2015-2020)

　4.4 Global mRNA Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global mRNA Vaccine Historic Market Analysis by Application

　5.1 Global mRNA Vaccine Sales Market Share by Application (2015-2020)

　5.2 Global mRNA Vaccine Revenue Market Share by Application (2015-2020)

　5.3 Global mRNA Vaccine Price by Application (2015-2020)

6 Company Profiles and Key Figures in mRNA Vaccine Business

　6.1 Company 1

　　6.1.1 Corporation Information

　　6.1.2 Company 1 Description, Business Overview and Total Revenue

　　6.1.3 Moderna TherapeutiRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.1.4 Company 1 Products Offered

　　6.1.5 Company 1 Recent Development

　6.2 Company 2

　　6.2.1 CureVaA Vaccine Production Sites and Area Served

　　6.2.2 Company 2 Description, Business Overview and Total Revenue

　　6.2.3 CureVaA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.2.4 Company 2 Products Offered

　　6.2.5 Company 2 Recent Development

　6.3 Company 3

　　6.3.1 Company 3 mRNA Vaccine Production Sites and Area Served

　　6.3.2 Company 3 Description, Business Overview and Total Revenue

　　6.3.3 Company 3 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.3.4 Company 3 Products Offered

　　6.3.5 Company 3 Recent Development

　6.4 Company 4

　　6.4.1 Company 4 mRNA Vaccine Production Sites and Area Served

　　6.4.2 Company 4 Description, Business Overview and Total Revenue

　　6.4.3 Company 4 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.4.4 Company 4 Products Offered

　　6.4.5 Company 4 Recent Development

　6.5 Company 5

　　6.5.1 Sangamo TherapeutiRNA Vaccine Production Sites and Area Served

　　6.5.2 Company 5 Description, Business Overview and Total Revenue

　　6.5.3 Sangamo TherapeutiRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.5.4 Company 5 Products Offered

　　6.5.5 Company 5 Recent Development

　6.6 Company 6

　　6.6.1 Argos TherapeutiRNA Vaccine Production Sites and Area Served

　　6.6.2 Company 6 Description, Business Overview and Total Revenue

　　6.6.3 Argos TherapeutiRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.6.4 Company 6 Products Offered

　　6.6.5 Company 6 Recent Development

　6.7 Company 7

　　6.6.1 Company 7 mRNA Vaccine Production Sites and Area Served

　　6.6.2 Company 7 Description, Business Overview and Total Revenue

　　6.6.3 Company 7 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.4.4 Company 7 Products Offered

　　6.7.5 Company 7 Recent Development

　6.8 Company 8

　　6.8.1 Company 8 mRNA Vaccine Production Sites and Area Served

　　6.8.2 Company 8 Description, Business Overview and Total Revenue

　　6.8.3 Company 8 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

全球疫苗基因行業分析及發展趨勢分析報告2020至2026年

　　6.8.4 Company 8 Products Offered

　　6.8.5 Company 8 Recent Development

　6.9 Company 9

　　6.9.1 Company 9 mRNA Vaccine Production Sites and Area Served

　　6.9.2 Company 9 Description, Business Overview and Total Revenue

　　6.9.3 Company 9 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.9.4 Company 9 Products Offered

　　6.9.5 Company 9 Recent Development

　6.10 Company 10

　　6.10.1 Company 10 mRNA Vaccine Production Sites and Area Served

　　6.10.2 Company 10 Description, Business Overview and Total Revenue

　　6.10.3 Company 10 mRNA Vaccine Sales, Revenue and Gross Margin (2015-2020)

　　6.10.4 Company 10 Products Offered

　　6.10.5 Company 10 Recent Development

7 mRNA Vaccine Manufacturing Cost Analysis

　7.1 mRNA Vaccine Key Raw Materials Analysis

　　7.1.1 Key Raw Materials

　　7.1.2 Key Raw Materials Price Trend

　　7.1.3 Key Suppliers of Raw Materials

　7.2 Proportion of Manufacturing Cost Structure

　7.3 Manufacturing Process Analysis of mRNA Vaccine

　7.4 mRNA Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

　8.1 Marketing Channel

　8.2 mRNA Vaccine Distributors List

　8.3 mRNA Vaccine Customers

9 Market Dynamics

　9.1 Market Trends

　9.2 Opportunities and Drivers

　9.3 Challenges

　9.4 Porter's Five Forces Analysis

10 Global Market Forecast

　10.1 Global mRNA Vaccine Market Estimates and Projections by Type

　　10.1.1 Global Forecasted Sales of mRNA Vaccine by Type (2021-2026)

　　10.1.2 Global Forecasted Revenue of mRNA Vaccine by Type (2021-2026)

　10.2 mRNA Vaccine Market Estimates and Projections by Application

　　10.2.1 Global Forecasted Sales of mRNA Vaccine by Application (2021-2026)

　　10.2.2 Global Forecasted Revenue of mRNA Vaccine by Application (2021-2026)

　10.3 mRNA Vaccine Market Estimates and Projections by Region

　　10.3.1 Global Forecasted Sales of mRNA Vaccine by Region (2021-2026)

　　10.3.2 Global Forecasted Revenue of mRNA Vaccine by Region (2021-2026)

　10.4 North America mRNA Vaccine Estimates and Projections (2021-2026)

　10.5 Europe mRNA Vaccine Estimates and Projections (2021-2026)

　10.6 Asia PacifiA Vaccine Estimates and Projections (2021-2026)

　10.7 Latin America mRNA Vaccine Estimates and Projections (2021-2026)

　10.8 Middle East and Africa mRNA Vaccine Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

　12.1 Methodology/Research Approach

　　12.1.1 Research Programs/Design

　　12.1.2 Market Size Estimation

　　12.1.3 Market Breakdown and Data Triangulation

　12.2 Data Source

　　12.2.1 Secondary Sources

　　12.2.2 Primary Sources

　12.3 Author List

　12.4 Disclaimer

List of Tables

　Table 1. Global mRNA Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)

　Table 2. Global mRNA Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026

　Table 3. Global mRNA Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)

　Table 4. Global Key mRNA Vaccine Manufacturers Covered in This Study

　Table 5. Global mRNA Vaccine Sales (K Doses) by Manufacturers (2015-2020)

　Table 6. Global mRNA Vaccine Sales Share by Manufacturers (2015-2020)

　Table 7. Global mRNA Vaccine Revenue (Million USD) by Manufacturers (2015-2020)

　Table 8. Global mRNA Vaccine Revenue Share by Manufacturers (2015-2020)

　Table 9. Global Market mRNA Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020)

　Table 10. Manufacturers mRNA Vaccine Sales Sites and Area Served

　Table 11. Manufacturers mRNA Vaccine Product Types

　Table 12. Global mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

　Table 13. Global mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine as of 2019)

　Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

　Table 15. Main Points Interviewed from Key mRNA Vaccine Players

　Table 16. Global mRNA Vaccine Sales (K Doses) by Region (2015-2020)

　Table 17. Global mRNA Vaccine Sales Market Share by Region (2015-2020)

　Table 18. Global mRNA Vaccine Revenue (Million US$) by Region (2015-2020)

　Table 19. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)

　Table 20. North America mRNA Vaccine Sales by Country (2015-2020) (K Doses)

　Table 21. North America mRNA Vaccine Sales Market Share by Country (2015-2020)

　Table 22. North America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

　Table 23. North America mRNA Vaccine Revenue Market Share by Country (2015-2020)

　Table 24. Europe mRNA Vaccine Sales by Country (2015-2020) (K Doses)

　Table 25. Europe mRNA Vaccine Sales Market Share by Country (2015-2020)

　Table 26. Europe mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

全球疫苗基因行業分析及發展趨勢分析報告2020至2026年

　Table 27. Europe mRNA Vaccine Revenue Market Share by Country (2015-2020)

　Table 28. Asia PacifiA Vaccine Sales by Region (2015-2020) (K Doses)

　Table 29. Asia PacifiA Vaccine Sales Market Share by Region (2015-2020)

　Table 30. Asia PacifiA Vaccine Revenue by Region (2015-2020) (US$ Million)

　Table 31. Asia PacifiA Vaccine Revenue Market Share by Region (2015-2020)

　Table 32. Latin America mRNA Vaccine Sales by Country (2015-2020) (K Doses)

　Table 33. Latin America mRNA Vaccine Sales Market Share by Country (2015-2020)

　Table 34. Latin America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

　Table 35. Latin America mRNA Vaccine Revenue Market Share by Country (2015-2020)

　Table 36. Middle East and Africa mRNA Vaccine Sales by Country (2015-2020) (K Doses)

　Table 37. Middle East and Africa mRNA Vaccine Sales Market Share by Country (2015-2020)

　Table 38. Middle East and Africa mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)

　Table 39. Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2015-2020)

　Table 40. Global mRNA Vaccine Sales (K Doses) by Type (2015-2020)

　Table 41. Global mRNA Vaccine Sales Share by Type (2015-2020)

　Table 42. Global mRNA Vaccine Revenue (Million US$) by Type (2015-2020)

　Table 43. Global mRNA Vaccine Revenue Share by Type (2015-2020)

　Table 44. Global mRNA Vaccine Price (USD/Dose) by Type (2015-2020)

　Table 45. Global mRNA Vaccine Sales (K Doses) by Application (2015-2020)

　Table 46. Global mRNA Vaccine Sales Market Share by Application (2015-2020)

　Table 47. Global mRNA Vaccine Sales Growth Rate by Application (2015-2020)

　Table 48. Moderna TherapeutiRNA Vaccine Corporation Information

　Table 49. Company 1 Description and Business Overview

　Table 50. Moderna TherapeutiRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 51. Moderna Therapeutiain Product

　Table 52. Company 1 Recent Development

　Table 53. CureVaA Vaccine Corporation Information

　Table 54. Company 2 Corporation Information

　Table 55. CureVaA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 56. Company 2 Main Product

　Table 57. Company 2 Recent Development

　Table 58. Company 3 mRNA Vaccine Corporation Information

　Table 59. Company 3 Corporation Information

　Table 60. Company 3 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 61. Company 3 Main Product

　Table 62. Company 3 Recent Development

　Table 63. Company 4 mRNA Vaccine Corporation Information

　Table 64. Company 4 Corporation Information

　Table 65. Company 4 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 66. Company 4 Main Product

　Table 67. Company 4 Recent Development

　Table 68. Sangamo TherapeutiRNA Vaccine Corporation Information

　Table 69. Company 5 Corporation Information

　Table 70. Sangamo TherapeutiRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 71. Sangamo Therapeutiain Product

　Table 72. Company 5 Recent Development

　Table 73. Argos TherapeutiRNA Vaccine Corporation Information

　Table 74. Company 6 Corporation Information

　Table 75. Argos TherapeutiRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 76. Argos Therapeutiain Product

　Table 77. Company 6 Recent Development

　Table 78. Company 7 mRNA Vaccine Corporation Information

　Table 79. Company 7 Corporation Information

　Table 80. Company 7 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 81. Company 7 Main Product

　Table 82. Company 7 Recent Development

　Table 83. Company 8 mRNA Vaccine Corporation Information

　Table 84. Company 8 Corporation Information

　Table 85. Company 8 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 86. Company 8 Main Product

　Table 87. Company 8 Recent Development

　Table 88. Company 9 mRNA Vaccine Corporation Information

　Table 89. Company 9 Corporation Information

　Table 90. Company 9 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 91. Company 9 Main Product

　Table 92. Company 9 Recent Development

　Table 93. Company 10 mRNA Vaccine Corporation Information

　Table 94. Company 10 Corporation Information

　Table 95. Company 10 mRNA Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

　Table 96. Company 10 Main Product

　Table 97. Company 10 Recent Development

　Table 98. Sales Base and Market Concentration Rate of Raw Material

　Table 99. Key Suppliers of Raw Materials

　Table 100. mRNA Vaccine Distributors List

　Table 101. mRNA Vaccine Customers List

　Table 102. Market Key Trends

　Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)

　Table 104. Key Challenges

　Table 105. Global mRNA Vaccine Sales (K Doses) Forecast by Type (2021-2026)

　Table 106. Global mRNA Vaccine Sales Market Share Forecast by Type (2021-2026)

　Table 107. Global mRNA Vaccine Revenue (Million US$) Forecast by Type (2021-2026)

　Table 108. Global mRNA Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)

　Table 109. Global mRNA Vaccine Sales (K Doses) Forecast by Application (2021-2026)

　Table 110. Global mRNA Vaccine Revenue (Million US$) Forecast by Application (2021-2026)

quánqiú yìmiáo jīyīn hángyè fēnxī jí fāzhǎn qūshì fēnxī bàogào 2020 zhì 2026 nián

　Table 111. Global mRNA Vaccine Sales (K Doses) Forecast by Region (2021-2026)

　Table 112. Global mRNA Vaccine Sales Market Share Forecast by Region (2021-2026)

　Table 113. Global mRNA Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)

　Table 114. Global mRNA Vaccine Revenue Market Share Forecast by Region (2021-2026)

　Table 115. Research Programs/Design for This Report

　Table 116. Key Data Information from Secondary Sources

　Table 117. Key Data Information from Primary Sources

List of Figures

　Figure 1. Picture of mRNA Vaccine

　Figure 2. Global mRNA Vaccine Sales Market Share by Type: 2020 VS 2026

　Figure 3. Standardization Of Cancer Treatment mRNA Vaccine Product Picture

　Figure 4. Individualized Cancer Treatment mRNA Vaccine Product Picture

　Figure 5. Infectious Disease Treatment mRNA Vaccine Product Picture

　Figure 6. Infection Prevention mRNA Vaccine Product Picture

　Figure 7. Global mRNA Vaccine Consumption Market Share by Application: 2020 VS 2026

　Figure 8. Infectious Disease

　Figure 9. Cancer

　Figure 10. Other

　Figure 11. Global mRNA Vaccine Market Size 2015-2026 (US$ Million)

　Figure 12. Global mRNA Vaccine Sales Capacity (K Doses) (2015-2026)

　Figure 13. Global mRNA Vaccine Market Size Market Share by Region: 2020 Versus 2026

　Figure 14. mRNA Vaccine Sales Share by Manufacturers in 2020

　Figure 15. Global mRNA Vaccine Revenue Share by Manufacturers in 2019

　Figure 16. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccine Revenue in 2019

　Figure 17. mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

　Figure 18. Global mRNA Vaccine Sales Market Share by Region (2015-2020)

　Figure 19. Global mRNA Vaccine Sales Market Share by Region in 2019

　Figure 20. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)

　Figure 21. Global mRNA Vaccine Revenue Market Share by Region in 2019

　Figure 22. North America mRNA Vaccine Sales Market Share by Country in 2019

　Figure 23. North America mRNA Vaccine Revenue Market Share by Country in 2019

　Figure 24. U.S. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 25. U.S. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 26. Canada mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 27. Canada mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 28. Europe mRNA Vaccine Sales Market Share by Country in 2019

　Figure 29. Europe mRNA Vaccine Revenue Market Share by Country in 2019

　Figure 30. Germany mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 31. Germany mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 32. France mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 33. France mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 34. U.K. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 35. U.K. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 36. Italy mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 37. Italy mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 38. Russia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 39. Russia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 40. Asia PacifiA Vaccine Sales Market Share by Region in 2019

　Figure 41. Asia PacifiA Vaccine Revenue Market Share by Region in 2019

　Figure 42. China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 43. China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 44. Japan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 45. Japan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 46. South Korea mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 47. South Korea mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 48. India mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 49. India mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 50. Australia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 51. Australia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 52. Taiwan, China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 53. Taiwan, China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 54. Indonesia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 55. Indonesia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 56. Thailand mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 57. Thailand mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 58. Malaysia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 59. Malaysia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 60. Philippines mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 61. Philippines mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 62. Vietnam mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 63. Vietnam mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 64. Latin America mRNA Vaccine Sales Market Share by Country in 2019

　Figure 65. Latin America mRNA Vaccine Revenue Market Share by Country in 2019

　Figure 66. Mexico mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 67. Mexico mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 68. Brazil mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 69. Brazil mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 70. Argentina mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 71. Argentina mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 72. Middle East and Africa mRNA Vaccine Sales Market Share by Country in 2019

　Figure 73. Middle East and Africa mRNA Vaccine Revenue Market Share by Country in 2019

　Figure 74. Turkey mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 75. Turkey mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 76. Saudi Arabia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

グローバルのmRNAワクチン業界分析と動向分析レポート2020-2026

　Figure 77. Saudi Arabia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 78. U.A.E mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)

　Figure 79. U.A.E mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

　Figure 80. Sales Market Share of mRNA Vaccine by Type (2015-2020)

　Figure 81. Sales Market Share of mRNA Vaccine by Type in 2019

　Figure 82. Revenue Share of mRNA Vaccine by Type (2015-2020)

　Figure 83. Revenue Market Share of mRNA Vaccine by Type in 2019

　Figure 84. Global mRNA Vaccine Sales Growth by Type (2015-2020) (K Doses)

　Figure 85. Global mRNA Vaccine Sales Market Share by Application (2015-2020)

　Figure 86. Global mRNA Vaccine Sales Market Share by Application in 2019

　Figure 87. Global Revenue Share of mRNA Vaccine by Application (2015-2020)

　Figure 88. Global Revenue Share of mRNA Vaccine by Application in 2020

　Figure 89. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 90. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 91. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 92. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 93. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 94. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 95. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 96. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 97. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 98. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 99. Price Trend of Key Raw Materials

　Figure 100. Manufacturing Cost Structure of mRNA Vaccine

　Figure 101. Manufacturing Process Analysis of mRNA Vaccine

　Figure 102. mRNA Vaccine Industrial Chain Analysis

　Figure 103. Channels of Distribution

　Figure 104. Distributors Profiles

　Figure 105. Porter's Five Forces Analysis

　Figure 106. North America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

　Figure 107. North America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

　Figure 108. Europe mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

　Figure 109. Europe mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

　Figure 110. Latin America mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

　Figure 111. Latin America mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

　Figure 112. Middle East and Africa mRNA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

　Figure 113. Middle East and Africa mRNA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

　Figure 114. Asia PacifiA Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)

　Figure 115. Asia PacifiA Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

　Figure 116. Bottom-up and Top-down Approaches for This Report

　Figure 117. Data Triangulation

　Figure 118. Key Executives Interviewed

　　http://www.5269660.cn/8/78/Global-mRNA-Vaccine-Industry-Analysis-and-Trends-Analysis-Report-2020-2026.html

　　產業調研網

　　…

掃一掃 “Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026”

如需購買《Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026》，編號：2733788
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn　　【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”

2024 mRNA Vaccine Research, Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026

訂閱Rss更新 下載電子版產業調研網 > 調研報告 > 醫藥保健行業 > Global mRNA Vaccine Industry Analysis and Trends Analysis Report 2020-2026